Enanta Pharmaceuticals Inc ENTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
48.75UNCH (UNCH)
Volume
4,286
Close
48.75quote price arrow down-0.56 (-1.14%)
Volume
118,265
52 week range
40.32 - 58.59

...

Loading . . .
  • Open49.27
  • Day High49.49
  • Day Low47.99
  • Prev Close49.31
  • 52 Week High58.59
  • 52 Week High Date05/19/20
  • 52 Week Low40.32
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap983.29M
  • Shares Out20.17M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change15.8

KEY STATS

  • Open49.27
  • Day High49.49
  • Day Low47.99
  • Prev Close49.31
  • 52 Week High58.59
  • 52 Week High Date05/19/20
  • 52 Week Low40.32
  • 52 Week Low Date12/29/20
  • Market Cap983.29M
  • Shares Out20.17M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change15.8

RATIOS/PROFITABILITY

  • EPS (TTM)-2.89
  • P/E (TTM)-16.87
  • Fwd P/E (NTM)-15.27
  • EBITDA (MRQ)-63.198M
  • ROE (MRQ)-12.40%
  • Revenue (MRQ)101.65M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-57.00%
  • Debt To Equity (MRQ)0.33%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Enanta Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Enanta Pharmaceuticals, Inc. is a biotechnology company. The Company uses chemistry-driven approach and drug discovery capabilities. The Company is focused on discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. The Company has clinical candidates for the disease targets, including respiratory syncytial virus (RSV), hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH). It also conducts research in human...
Bruce Carter Ph.D.
Non-Executive Chairman
Jay Luly Ph.D.
President
Paul Mellett Jr.
Chief Financial Officer
Address
500 Arsenal St
Watertown, MA
02472-2806
United States

Top Peers

SYMBOLLASTCHG%CHG
PSNL
Personalis Inc
23.02-0.12-0.52%
MNKD
MannKind Corp
4.24-0.08-1.85%
KPTI
Karyopharm Therapeutics Inc
10.02-0.12-1.18%
CARA
Cara Therapeutics Inc
29.19+1.72+6.26%
CDMO
Avid Bioservices Inc
19.39-0.56-2.81%